In BC, CCL2 activates SRC and PKC signaling pathways through its receptor CCR2, which in turn negatively regulates the expression of cell cycle inhibitory protein p27KIP1 and releases cell cycle inhibition (180). This evidence concerns the gene CCL2 and breast cancer.